Smart pump trial aims to tame tough diabetes cases
NCT ID NCT07509060
First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study tests a hybrid closed-loop insulin pump system (mylife CamAPS FX) in 30 adults with type 1 diabetes who have chronically high blood sugar and psychological challenges. Participants either start the pump immediately or after a 3-month delay. The goal is to see if the system improves glucose control and quality of life. This is not a cure, but a way to better manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Silesia in Katowice, Poland
Katowice, Poland
-
Poznan University of Medical Science, Poland
Poznan, Poland
-
University Hospital in Krakow
Krakow, Poland
Conditions
Explore the condition pages connected to this study.